Biosimilars: A revolution for biologics in the pharmaceutical industry
This project report is submitted in partial fulfilment of the requirements for the degree of Bachelor of Pharmacy, 2017.
Autor principal: | Moreino, Shannon Sherwin |
---|---|
Otros Autores: | Kabir, Eva Rahman |
Formato: | Project report |
Lenguaje: | English |
Publicado: |
BRAC University
2018
|
Materias: | |
Acceso en línea: | http://hdl.handle.net/10361/9331 |
Ejemplares similares
-
Biologics and Biosimilars as Treatment Options for Psoriasis
por: Moya, Amena Khatun
Publicado: (2023) -
Biosimilar in lymphoma treatment
por: Tanisha, Mehrin Haque
Publicado: (2021) -
Biosimilar insulins: a potential option in the treatment of Diabetes
por: Tabassum, Turana
Publicado: (2022) -
Concepts and challenges of biosimilars to mitigate the oncology drug expenses
por: Tania, Umme
Publicado: (2021) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
por: Tania, Umme
Publicado: (2023)